General Statement of Disclosure:

CONSULTING FEES/HONORARIA: NovoNordisk(SIGNIFICANT), Altimmune(MODEST), MJH Life Sciences(MODEST), New Amsterdam(MODEST), Idorsia(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: Novartis(MODEST), Boehringer Ingelheim Pharmaceuticals, Inc(MODEST) OTHER FINANCIAL BENEFIT: Esperion(SIGNIFICANT)

View Full Disclosure